Pediatric Neurooncology

  • Functional and Structural Genomics
  • KiTZ
Employee image

Prof. Dr. Stefan Pfister

Head of Division

Pediatric Neurooncology is currently a vibrant field of research. This is desperately needed, since brain tumors have become the number one cause of cancer-related mortality in children. Our group aims to bridge the gap between generating genomic screening data as well as faithful models for preclinical drug testing, and exploiting these data for the sake of our patients.

Our research

Pediatric neurooncology - research for better therapies

Brain tumors are the most common cause of cancer-related death in children. While molecular findings have already been successfully integrated into clinical practice in hemato-oncology, neuro-oncology still faces major challenges. Our aim is to better understand the biological basis of childhood brain tumors and to develop new therapeutic approaches.

Our research approach

We analyze tumors genetically using state-of-the-art high-throughput sequencing and make these findings usable for clinical application. This includes the identification and validation of biomarkers that enable predictions to be made about the course of the disease and the response to therapy. We also test new treatment approaches in preclinical models, often in combination with proven chemotherapeutic agents, in order to develop personalized therapies.

Childhood brain tumors are biologically extremely diverse, both between different tumor types and within a single tumor. This diversity makes it difficult to tailor treatments. Our research helps to decipher these genetic and epigenetic differences. Using preclinical models and state-of-the-art sequencing technologies, we investigate tumor development, metastasis and relapse. We are also investigating tumor-specific changes in cerebrospinal fluid and blood plasma in order to develop new diagnostic markers and better monitor therapeutic success.

Our goal: a better understanding of childhood brain tumors and innovative, individual treatment options for affected children.

Team

  • Employee image

    Prof. Dr. Stefan Pfister

    Head of Division

  • Employee image

    Dr. Marcel Kool

    Group Leader

  • Employee image

    Dr. Robert Autry

    Group Leader

  • Employee image

    Dr. Kendra Maaß

    Group Leader

  • Employee image

    Dr. Kristian Pajtler

    Group Leader

  • Employee image

    Dr. Supat Thongjuea

    Group Leader

  • Employee image

    Dr. Marc Zuckermann

    Group Leader

Entire Team

Selected publications

2025 - Neuro Oncol . 2025 Jan 12;27(1):222-236
2024 - Nature. 2024 Jan;625(7996):788-796
2024 - Nat Commun . 2024 Jan 8;15(1):269

Latest publications

Get in touch with us

Employee image
Prof. Dr. Stefan Pfister
Head of Division
Employee image
Ines Hofmann
Sekretariat
Employee image
Jasmin Luisa Müller
Secretariat
Form

Form data is loaded ...